1.
Falk RH,
Comenzo RL,
Skinner M.
The systemic amyloidoses.
N Engl J Med.
1997;337:898-909.
2.
Koyama J,
Falk RH.
Prognostic significance of strain Doppler imaging in light-chain amyloidosis.
JACC Cardiovasc Imaging.
2010;3:333-342.
3.
Selvanayagam JB,
Hawkins PN,
Paul B,
Myerson SG,
Neubauer S.
Evaluation and management of the cardiac amyloidosis.
J Am Coll Cardiol.
2007;50:2101-2110.
4.
Austin BA et al.
Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
JACC Cardiovasc Imaging.
2009;2:1369-1377.
5.
Maceira AM et al.
Cardiovascular magnetic resonance in cardiac amyloidosis.
Circulation.
2005;111:186-193.
6.
Maceira AM,
Prasad SK,
Hawkins PN,
Roughton M,
Pennell DJ.
Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.
J Cardiovasc Magn Reson.
2008;10:54.
7.
Syed IS et al.
Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
JACC Cardiovasc Imaging.
2010;3:155-164.
8.
Vogelsberg H et al.
Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy.
J Am Coll Cardiol.
2008;51:1022-1030.
9.
Mark DB et al.
ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
J Am Coll Cardiol.
2010;55:2663-2699.
10.
Montalescot G et al.
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Eur Heart J.
2013;34:2949-3003.
11.
Baks T et al.
Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT.
AJR Am J Roentgenol.
2007;188:W135-W137.
12.
Gerber BL et al.
Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance.
Circulation.
2006;113:823-833.
13.
Nieman K et al.
Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging.
Radiology.
2008;247:49-56.
14.
Rodriguez-Granillo GA et al.
Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention.
JACC Cardiovasc Imaging.
2009;2:1072-1081.
15.
Sato A et al.
Prognostic value of myocardial contrast delayed enhancement with 64-slice multidetector computed tomography after acute myocardial infarction.
J Am Coll Cardiol.
2012;59:730-738.
16.
Zhao L et al.
Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography.
Eur Radiol.
2013;23:1034-1043.
17.
Dambrin G,
Laissy JP,
Serfaty JM,
Caussin C,
Lancelin B,
Paul JF.
Diagnostic value of ECG-gated multidetector computed tomography in the early phase of suspected acute myocarditis.
A preliminary comparative study with cardiac MRI.
Eur Radiol.
2007;17:331-338.
18.
Bandula S et al.
Measurement of Tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging.
Radiology.
2013;268:858-864.
19.
Banypersad SM et al.
Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study.
Circ Cardiovasc Imaging.
2013;6:34-39.
20.
Canet EP,
Janier MF,
Revel D.
Magnetic resonance perfusion imaging in ischemic heart disease.
J Magn Reson Imaging.
1999;10:423-433.
21. Weinmann HJ,
Brasch RC,
Press WR,
Wesbey GE.
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.
AJR Am J Roentgenol.
1984;142:619-624.
22.
Mahrholdt H,
Wagner A,
Judd RM,
Sechtem U,
Kim RJ.
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
Eur Heart J.
2005;26:1461-1474.
23.
Bourin M,
Jolliet P,
Ballereau F.
An overview of the clinical pharmacokinetics of x-ray contrast media.
Clin Pharmacokinet.
1997;32:180-193.
24.
Paul JF et al.
Late defect on delayed contrast-enhanced multi-detector row CT scans in the prediction of SPECT infarct size after reperfused acute myocardial infarction: initial experience.
Radiology.
2005;236:485-489.
25.
Kartje JK,
Schmidt B,
Bruners P,
Mahnken AH.
Dual energy CT with nonlinear image blending improves visualization of delayed myocardial contrast enhancement in acute myocardial infarction.
Invest Radiol.
2013;48:41-45.